Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • COMPLEXES  (2)
  • GENES  (2)
Keywords
  • 1
    Keywords: SPECTRA ; EXPRESSION ; IN-VITRO ; Germany ; VITRO ; GENE ; GENES ; PROTEIN ; PROTEINS ; PATIENT ; FAMILY ; SKIN ; SEQUENCE ; chromosome ; ACID ; IDENTIFICATION ; MUTATION ; MUTATIONS ; EPIDERMAL DIFFERENTIATION ; PHENOTYPE ; point mutation ; ARACHIDONIC-ACID ; EUROPE ; NOMENCLATURE ; CHROMOSOME 17P13.1 ; GENE-PRODUCT ; molecular ; ENZYME-ACTIVITIES ; ENZYME ; MISSENSE MUTATION ; MUTANTS ; recombinant protein ; SUBFAMILY ; ALOX12B ; ALOXE3 ; COLLODION BABY ; congenital ichthyosis ; genodermatosis ; genotype/phenotype correlation ; hepoxilin ; HEPOXILINS ; LAMELLAR ICHTHYOSIS ; lipoxygenase
    Abstract: Autosomal,recessive congenital ichthyosis (ARCI) is a clinically and genetically heterogeneous group of severe hereditary keratinization disorders characterized by intense scaling of the whole integument, and differences in color and shape. It is often associated with erythema. To date, six loci for ARCI. have been mapped. Mutations in ALOXE3 and ALOX12B on chromosome 17p13, which code for two different epidermal lipoxygenases, were recently found in patients with ichthyosiform erythroderma from Turkey, France, and North Africa. Here we describe molecular and clinical findings in 17 families with ARCI originating from Central Europe, Turkey, and the Indian subcontinent, with mutations in ALOXE3 or ALOX12B. We identified 11 novel point mutations in ALOX12B (one nonsense mutation and 10 missense mutations) and four different inactivating mutations in ALOXE3. The gene products of ALOX12B and ALOXE3, the epidermal lipoxygenases 12R-LOX and eLOX3 respectively, are preferentially synthesized in the skin. They act in sequence to convert arachidonic acid via 12(R)-HPETE to the corresponding epoxyalcohol, 8(R)-hydroxy,11(R),12(R)-epoxyeicosatrienoic acid. To assess the impairment of enzyme activity, we expressed the mutated genes in vitro and determined the activity of the recombinant proteins toward their genuine substrates. All but one of the recombinant mutants were enzymatically inactive. The characterization of disease-causing mutations in ALOXE3 and ALOX12B and the resulting ARCI phenotypes did not result in clear diagnostic criteria; however, we found a first correlation between the genetic findings and the clinical presentation of ichthyosis
    Type of Publication: Journal article published
    PubMed ID: 16116617
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: CANCER ; CANCER CELLS ; CELLS ; tumor ; human ; NEW-YORK ; RISK ; GENE ; PROTEIN ; PROTEINS ; TUMORS ; COMPLEX ; COMPLEXES ; INFECTION ; RISK-FACTORS ; CARCINOGENESIS ; MUTATION ; cervical cancer ; CERVICAL-CANCER ; p53 ; CANCER-CELLS ; HPV ; DEGRADATION ; ONCOPROTEIN ; HUMAN-PAPILLOMAVIRUS TYPE-16 ; human papilloma virus ; TP53 ; CARCINOMA CELL-LINES ; E6 ONCOPROTEIN ; E6-mediated p53 inactivation ; E6AP ; HPV INFECTION ; MULTICENTRIC CASE-CONTROL ; P53 CODON- 72 POLYMORPHISM ; UBE3A
    Abstract: Functional loss of the tumor suppressor p53 by alterations in its TP53 gene is a frequent event in cancers of different anatomical regions. Cervical cancer is strongly linked to infection by high-risk human papillomavirus (HPV) types. The viral oncoprotein E6 has the ability to associate with and neutralize the function of p53. E6 interacts with a 100-kDa cellular protein, termed E6 associated protein (E6AP; also called ubiquitin-protein ligase E3A or UBE3A), which functions as an ubiquitin protein ligase. The dimeric complex then binds p53 and E6AP catalyzes multi-ubiquitination and degradation of p53. The ability to promote p53 degradation is an exclusive property of E6 from the high,risk HPV types. Indeed, the low- risk E6 proteins lack this activity, although they can bind p53. Consistent with the E6 function of the high-risk HPV types, the majority of cervical cancer cells have a wild type p53 gene, but the protein levels are strongly decreased. Several independent studies have shown that in a small percentage of cervical tumors the p53 gene is mutated. However, this event appears to be unrelated to the presence or absence of HPV infection and the nature of the tumor
    Type of Publication: Journal article published
    PubMed ID: 12619117
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: CANCER ; CELL ; COMMON ; LUNG-CANCER ; DISEASE ; POPULATION ; RISK ; RISKS ; GENE ; GENES ; GENOME ; GENETIC POLYMORPHISMS ; cell cycle ; CELL-CYCLE ; CYCLE ; ASSOCIATION ; polymorphism ; POLYMORPHISMS ; SUSCEPTIBILITY ; VARIANTS ; FREQUENCIES ; BREAST-CANCER ; genetics ; colorectal cancer ; COLORECTAL-CANCER ; CDKN2A ; ADENOCARCINOMAS ; TP53 ; RECTAL-CANCER ; VARIANT ; GENOTYPE ; HAPLOTYPES ; USA ; rectal cancer ; INCREASED RISK ; CANCERS ; Colorectal cancer susceptibility ; Haplotype analysis ; CRC ; CDKN1A ; P53 GENOTYPES ; WIDE ASSOCIATION SCAN
    Abstract: The Czech Republic has one of the highest incidences of colorectal cancer (CRC) in the world. To assess the role of genetic variants on the disease, we genotyped polymorphisms in the TP53 (rs17878362: A(1)〉A(2), rs1042522:G〉C, rs12947788: C〉T, and rs17884306:G〉A), CDKN1A (rs1801270: C〉A and rs1059234:C〉T), and CDKN2A (rs3731249:G〉A, rs11515:C〉G, and rs3088440: C〉T) genes in 614 hospital-based CRC cases and 614 matched controls from the country. Despite the tendency toward differential distribution of variant allele frequencies for some polymorphisms, none was significantly associated with CRC risk. We observed differential distribution of major haplotypes arising from four polymorphisms ill the TP53 gene between cases and controls (global P〈0.0001). The two most common haplotypes, A(1)GCG and A(2)CCG, were present in 81% of the cases compared to 71% of the controls. In comparison to the most common haplotype (A(1)GCG), the haplotype A2CCG was associated with an increased risk (odds ratio (OR], 1.40; 95% confidence interval [CI], 1.07-1.82), while the four other haplotypes A(1)CCG (OR, 0.60; 95% CI, 0.45-0.79), A(2)GCG (OR, 0.53; 95% CI, 0.35-0.81), A(1)GTG (OR, 0.31; 95% CI, 0.15-0.64), and A(1)GCA (OR, 0.19; 95% CI, 0.07-0.51) were associated with a decreased risk. The effect of haplotypes in the TP53 gene was similar in colon (global P 〈 0.000 1) and rectal cancers (P = 0.006). No association with the disease was observed with haplotypes of the CDKN1A and CDKN2A polymorphisms. The results from this study suggest that prevalent haplotypes within the TP53 gene may modulate CRC risks in the population. Hum Mutat 30, 661-668, 2009. (C) 2009 Wiley-Liss, Inc
    Type of Publication: Journal article published
    PubMed ID: 19224585
    Signatur Availability
    BibTip Others were also interested in ...
  • 4
    Keywords: CANCER ; DISEASE ; RISK ; COMPLEX ; COMPLEXES ; SUSCEPTIBILITY ; VARIANTS ; COMMON DISEASES ; GENOME-WIDE ASSOCIATION ; MACULAR DEGENERATION ; CROHN-DISEASE
    Type of Publication: Journal article published
    PubMed ID: 21031564
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...